Furthermore, as a subtype of NEPC cells, small cell neuroendocrine carcinoma (SCNC) is often seen in patients with advanced disease, and is composed of pure neuroendocrine (NE) tumor cells [7] that express PCa stem cell marker CD44 [8-10]. The gene discussed is CD44; the disease is posterior cortical atrophy.